期刊文献+

口服头孢菌素类药物对肺炎链球菌肺炎大鼠肠道菌群的影响 被引量:18

Influence of oral cephalosporin drugs on intestinal flora in pneumococcal pneumonia rat
下载PDF
导出
摘要 目的观察临床常用口服头孢菌素类药物头孢克洛、头孢地尼和头孢克肟对肺炎链球菌感染大鼠肠道菌群的影响。方法选取健康SD大鼠,随机分为五组,其中一组为正常对照组,其余四组采用气管内直接注入菌液的方法建立肺炎链球菌肺炎大鼠模型,造模成功后随机分为未治疗组、头孢克洛组、头孢地尼组和头孢克肟组,灌胃给予不同头孢菌素进行治疗,每日2次,连续用药5 d后取各组大鼠粪便标本进行快速涂片镜检,取大肠内容物进行肠球菌、肠道杆菌和念珠菌的定量培养和肠道内细菌的菌种鉴定,对肠道菌群进行定量分析。结果连续应用头孢克洛、头孢地尼和头孢克肟治疗5 d,能够对肠道菌群中球菌和杆菌的比例产生不同程度的影响。与感染后未治疗组相比,应用头孢菌素类药物均导致肠道双歧杆菌和乳酸杆菌数量显著减少(P<0.05),念珠菌数量增多(P<0.05)。正常对照组中仅检出大肠埃希菌和粪肠球菌。与感染后未治疗组相比,应用头孢菌素治疗后感染大鼠肠道内的大肠埃希菌和粪肠球菌的检出率表现出不同程度的减少,其中头孢地尼治疗后粪肠球菌检出率下降最为显著,由100%降低至50%,仅5例检出粪肠球菌。肺炎链球菌感染后未治疗组,新检出2例肺炎克雷伯杆菌,1例变形杆菌。与感染后未治疗组相比,应用头孢菌素类药物治疗后变形杆菌、铜绿假单胞菌和屎肠球菌的检出例数明显增多,但肠道内优势菌仍是大肠埃希菌和粪肠球菌。结论口服头孢菌素类药物可导致肠道内优势菌群减少,条件致病菌增多,引起肠道微生态环境紊乱。 Objective To observe the influence of oral Cefaclor, Cefdinir and Cefixime on intestinal flora in streptococcus pneumoniae infection rats. Methods Healthy SD rats were selected and randomly assigned to five groups,one normal control group, and the other four groups were established rat model of pneumococcal pneumonia by intratracheal injection of bacteria liquid directly. Then the successful model rats were divided into untreated group,Cefaclor group, Cefdinir group and Cefixime group. The pneumococcal pneumonia rats were treated with the three oral cephalosporin drugs by intragastric administration twice daily for 5 days. After the treatment, stool specimens were collected for smear microscopic examination and colonic contents samples for quantitative analysis of intestinal flora,including quantitative culture and identification of bacterial strains. Results The proportion of coccus and bacillus in intestinal flora were changed after continuous application of Cefaclor, Cefdinir and Cefixime treatment for 5 days.Compared with the untreated group, intestinal Bifidobacteria and Lactobacilli significantly reduced after treatment with cephalosporins(P〈0.05), and number of Candida increased(P〈0.05). Moreover, Escherichina coli and Enterococcus faecalis were only detected in the normal control group. Compared with the untreated group, the detection rates of intestinal Escherichina coli and Enterococcus faecalis showed different degrees of reduction after treatment with cephalosporins. Intestinal Enterococcus faecalis reduced with the reduction from 100% to 50% after treatment with Cefdinir, only 5 cases detected Enterococcus faecalis. After Streptococcus pneumoniae infection, in untreated group 2 cases of Klebsiella pneumoniae and 1 case Proteuswere newly detected. Compared with the untreated group, the detection rates of Proteus, Pseudomonas aeruginosa and Enterococcus faecium significantly increased, but Escherichia coli and Enterococcus faecalis were still dominant flora in the intestine. Conclusion Oral cephalosporin drugs can decrease the intestinal dominant microflora and increase the intestinal opportunistic pathogens, causing disorder of intestinal microecology environment.
出处 《中国医药导报》 CAS 2015年第28期9-13,共5页 China Medical Herald
基金 国家自然科学基金资助项目(81471997 81001460 30901813)
关键词 头孢克洛 头孢地尼 头孢克肟 肺炎链球菌 肠道菌群 Cefaclor Cefdinir Cefixime Streptococcus pneumoniae Intestinal flora
  • 相关文献

参考文献20

  • 1Pneumococcal vaccines WHO position paper-2012 [J]. Wkly Epidemiol Rec, 2012,87(14) : 129-144.
  • 2Pellegrino P,Carnovale C,Perrone V,et al. Epidemiological analysis on two decades of hospitalisations for meningitis in the United States [J]. Eur J Clin Microbi01 Infect Dis, 2014,33(9) : 1519-1524.
  • 3邢文亚,赵惠君.儿童社区获得性肺炎诊治研究[J].临床儿科杂志,2015,33(4):334-337. 被引量:20
  • 4黄孟启,卓晓娅.儿童社区获得性肺炎的致病菌分布及耐药性分析[J].中国微生态学杂志,2015,27(5):581-583. 被引量:9
  • 5Van der Veen EL,Schilder AG,Timmers TK,et al. Effect of long-term trimethoprim/sulfamethoxazole treatment on resistance and integron prevalence in the intestinal flora: a randomized, double-blind, placebo-controlled trial in children [J]. J Antimicrob Chemother, 2009,63 (5) : 1011 - 1016.
  • 6Kirchner M, Mafura M, Hunt T,et al. Antimicrobial resis- tance characteristics and fitness of Gram-negative fecal bacteria from volunteers treated with minocycline or amox- icillin [J]. Front Microbiol,2014,5(722) : 1-9.
  • 7Lauw FN, Branger J, Florquin S, et al. IL- 18 improvesthe early antimicrobial host response to pneumococcal pneu- monia [J]. J Immunol, 2002,168 (1) : 372-378.
  • 8Golden AR, Rosenthal M, Fultz B, et al. Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13 [J]. J Antimicrob Chemother,2015,70(8):2199- 2202.
  • 9Chauvin C,Le Devendec L,Jouy E,et al. National preva- lence of resistance to third-generation cephalosporins in Escherichia coli isolates from layer flocks in France [J]. Antimicrob Agents Chemother, 2013,57 (12) : 6351-6353.
  • 10Zilberberg MD, Shorr AF. Prevalence of muhidrug-resis- rant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009 [J]. J Hosp Med, 2013,8 (10) : 559-563.

二级参考文献20

  • 1陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:605
  • 2Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community ac- quired pneumonia in children., update 2011 [J]. Thorax, 2011, 66(Supp12): ii1-ii23.
  • 3Don M, Canciani M, Corppi M. Community-acquired pneumonia in children: what's old? what's new? [J]. Acta Paediatr, 2010, 99(11): 1602-1608.
  • 4Garcia ML, Calvo C, Pozo F, et al. Spectrum of respiratory viruses in children with community-acquired pneumonia [J]. Pediatr Infect Dis J, 2012, 31(8): 808- 813.
  • 5Clinical and Laboratory Standards Institute/NCCLS. Performance standards for antimicrobial susceptibility testing, Fifteenth informa- tional supplement CLSI documentM100-S15[ S]. Clinical and Labo- ratory Standards Institute Wayne Pennsylvania, 2005, 25 ( 1 ) : 1- 106.
  • 6Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemialogy and eti- ology of childhood pneumonia[J]. Bull World Health Organ, 2008, 86(5) : 408-416.
  • 7Thiem U, Heppner HJ, Pientka L. Elderly patients with communi- ty-acquired pneumonia: optimal treatment strategies[ J]. Drugs Ag- ing, 2011, 28(7): 519-537.
  • 8Falade AG, Ayede AI. Epidemiology, aetiology and management of childhood acute community-acquired pneumonia in developing coun- tries-a review[J]. Afr J Med Sci, 2011, 40(4) : 293-308.
  • 9Sridhar RN, Basavarappa KG, Krishna GL. Detection of extended spectrum beta -lactamase from clinical isolates in Davangere [ J ]. In- dian J Pathol Microbiol 2008, 51 (4) : 497-499.
  • 10袁壮,陆权,万莉雅,邓力,陈小友,李昌崇,胡仪吉,洪建国,季伟,赵顺英,曹玲,崔振泽,董宗祈,鲁继荣.肺炎支原体肺炎的诊治[J].中国实用儿科杂志,2008,23(8):561-572. 被引量:256

共引文献32

同被引文献186

引证文献18

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部